Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
-0.89%
1,083.04
-9.76
-0.89%
—1,092.801,093.681,094.851,081.97——
SIXC
Communications
SIXC
Communications
SIXC
-0.39%
602.38
-2.36
-0.39%
—604.74604.74605.10601.34——
SIXE
Energy
SIXE
Energy
SIXE
+2.31%
1,242.83
+28.03
+2.31%
—1,214.801,220.811,243.821,220.81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.62%
1,713.82
-10.75
-0.62%
—1,724.571,727.021,732.301,707.43——
SIXM
Financials
SIXM
Financials
SIXM
+0.09%
639.99
+0.56
+0.09%
—639.43641.58644.53637.50——
SIXR
Staples
SIXR
Staples
SIXR
-0.20%
837.46
-1.69
-0.20%
—839.15836.90840.48832.89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.65%
214.22
-1.40
-0.65%
—215.62215.62216.21213.48——
SIXT
Technology
SIXT
Technology
SIXT
+0.78%
3,204.38
+24.86
+0.78%
—3,179.523,191.503,205.093,177.75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.23%
925.38
-11.53
-1.23%
—936.91935.42937.17923.20——
SIXV
Health care
SIXV
Health care
SIXV
-0.69%
1,442.71
-10.06
-0.69%
—1,452.771,445.931,447.431,434.91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.16%
2,361.34
-3.84
-0.16%
—2,365.182,353.642,368.102,347.80——
RDY:NYSE
Dr Reddy's Laboratories Ltd
US$ 13.73
-2.14%
(-0.30) Siku 1
US$ 13.73
0.00% (0.00)
Baada ya saa
Imefungwa: 29 Apr, 16:00:03 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya RDY...
Fungua
US$ 13.84
Juu
US$ 13.95
Chini
US$ 13.68
Mtaji wa soko
11.72B
Wastani wa kiasi cha mauzo
2.32M
Kiasi cha mauzo ya hisa
82.00
Gawio
0.67%
Mgawo wa faida wa kila robo mwaka
US$ 0.02
Tarehe ya kutojumuisha gawio
16 Jul 2024
Uwiano wa bei ya hisa na mapato kwa kila hisa
19.12
Juu kwa wiki 52
US$ 16.17
Chini kwa wiki 52
US$ 12.77
EPS
US$ 0.72
Beta
0.37
Hisa za wawekezaji
834.62M
Idadi ya wafanyakazi
elfu 28
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Kuhusu Dr Reddy's Laboratories Ltd
Afisa Mkuu Mtendaji (CEO)Erez Israeli
Wafanyakazielfu 27.8
Lilianzishwa1984
Makao makuuHyderabad, Andhra Pradesh, India
Sekta-
Tovutidrreddys.com
Ripoti ya mwisho
21 Jan 2026
Kipindi cha Kifedha
Robo3 2026
Mapato Yaliyosawazishwa kwa Kila Hisa au Kadirio
14.77/ (14.27 inakadiriwa)INR
+3.51%umepitiliza
Mapato au Kadirio
87.27B/ (84.52B inakadiriwa)INR
+3.25%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 3 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasariMaarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika INR
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika INR
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
85.06B
85.45B
88.05B
87.27B
Gharama ya bidhaa zilizouzwa
37.80B
36.82B
39.91B
40.46B
Gharama ya mapato
37.80B
36.82B
39.91B
40.46B
Gharama za utafiti na maendeleo
7.26B
6.24B
6.20B
6.15B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
24.06B
25.65B
26.44B
26.92B
Gharama ya uendeshaji
29.92B
31.11B
31.90B
32.48B
Jumla ya gharama za uendeshaji
67.71B
67.94B
71.81B
72.94B
Mapato ya uendeshaji
17.35B
17.52B
16.24B
14.33B
Mapato mengine yasiyo ya uendeshaji
719.00M
-
1.28B
570.00M
EBT ikijumuisha vipengee visivyo vya kawaida
20.05B
19.05B
18.35B
15.43B
EBT bila kujumuisha vipengee visivyo vya kawaida
19.76B
18.36B
17.81B
15.52B
Gharama ya kodi ya mapato
4.18B
4.95B
4.08B
3.53B
Kiwango cha kodi kinachotumika
20.85%
25.99%
22.24%
22.90%
Gharama nyingine za uendeshaji
-1.40B
-779.00M
-740.00M
-591.00M
Mapato halisi
15.94B
14.18B
14.37B
12.10B
Kiwango cha faida halisi
18.74%
16.59%
16.32%
13.86%
Mapato kwa kila hisa
19.84
17.02
17.87
14.77
Mapato ya riba na uwekezaji
564.00M
1.13B
912.00M
796.00M
Gharama ya riba
-656.00M
-830.00M
-907.00M
-944.00M
Jumla ya gharama halisi za riba
-92.00M
298.00M
5.00M
-148.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
20.65B
22.28B
21.29B
19.54B
Faida au hasara kutokana na uuzaji wa vipengee
-1.07B
40.00M
-308.00M
-179.00M
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho